Jagdeep Hundal, MD
Otolaryngology · Newark, DENPI 1467639864
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 88.8% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $3,480, more than ten times the $131 reported in 2019. Among otolaryngology clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $76.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$5K
- Acclarent, Inc$160
- GSK$117
- Insulet Corporation$91
- Regeneron Healthcare Solutions, Inc.$60
- Optinose US, Inc.$54
- plus $166 from 7 others
What the payments were for
- Consulting fees$2,61345%
- Travel & lodging$56910%
- Food & beverage$2,57645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 48 | $5,110 |
| Acclarent, Inc | 5 | $160 |
| GSK | 6 | $117 |
| Insulet Corporation | 2 | $91 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Optinose US, Inc. | 3 | $54 |
| Sanofi | 3 | $47 |
| Abbott | 1 | $28 |
| Pharming Healthcare, Inc. | 1 | $21 |
| Acerus Pharmaceuticals Corporation | 1 | $19 |
| AbbVie | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$4,029
How this compares
$5,757 in reported general payments places this provider in the 95th percentile of 27 otolaryngology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 79 | $3,392 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 20 | $2,266 |
| Mometasone Furoate | 17 | $2,086 |
| Fluticasone Propionate | 139 | $1,537 |
| Omeprazole | 61 | $904 |
| Azelastine Hcl | 25 | $859 |
| Nortriptyline Hcl | 54 | $762 |
| Montelukast Sodium | 27 | $485 |
| Fluocinolone Acetonide Oil | 13 | $454 |
| Levocetirizine Dihydrochloride | 18 | $237 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $210 |
| Levothyroxine Sodium | 27 | $185 |
| Mupirocin | 21 | $134 |
| Prednisone | 45 | $126 |
| Doxycycline Hyclate | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Newark
- David LaffertyNewark$9K
- Todd SpockNewark$4K
- Robert WardlowNewark$3K
- Gregg GoldsteinNewark$2K
- Julian AminNewark$1K
- John McIntireNewark$1K
- William SheppardNewark$778
- Avishai Stahl AltmanNewark$111
- Jonathan RomakNewark$93
- Robert WittNewark$54
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.